| Year |
Citation |
Score |
| 2020 |
Slyper M, Porter CBM, Ashenberg O, Waldman J, Drokhlyansky E, Wakiro I, Smillie C, Smith-Rosario G, Wu J, Dionne D, Vigneau S, Jané-Valbuena J, Tickle TL, Napolitano S, Su MJ, ... ... Haq R, et al. A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nature Medicine. 26: 792-802. PMID 32405060 DOI: 10.1038/S41591-020-0844-1 |
0.304 |
|
| 2020 |
Gstalder C, Liu D, Miao D, Lutterbach B, DeVine AL, Lin C, Shettigar M, Pancholi P, Buchbinder EI, Carter SL, Manos MP, Rojas-Rudilla V, Brennick R, Gjini E, Chen PH, ... ... Haq R, et al. Inactivation of Fbxw7 impairs dsRNA sensing and confers resistance to PD-1 blockade. Cancer Discovery. PMID 32371478 DOI: 10.1158/2159-8290.Cd-19-1416 |
0.33 |
|
| 2020 |
Kurppa KJ, Liu Y, To C, Zhang T, Fan M, Vajdi A, Knelson EH, Xie Y, Lim K, Cejas P, Portell A, Lizotte PH, Ficarro SB, Li S, Chen T, ... ... Haq R, et al. Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway. Cancer Cell. 37: 104-122.e12. PMID 31935369 DOI: 10.1016/J.Ccell.2019.12.006 |
0.438 |
|
| 2020 |
Persky NS, Hernandez D, Do Carmo M, Brenan L, Cohen O, Kitajima S, Nayar U, Walker A, Pantel S, Lee Y, Cordova J, Sathappa M, Zhu C, Hayes TK, Ram P, ... ... Haq R, et al. Defining the landscape of ATP-competitive inhibitor resistance residues in protein kinases. Nature Structural & Molecular Biology. 27: 92-104. PMID 31925410 DOI: 10.1038/S41594-019-0358-Z |
0.367 |
|
| 2020 |
Buchbinder EI, Cohen JV, Haq R, Hodi FS, Lawrence DP, Giobbie-Hurder A, Knoerzer D, Sullivan RJ. A phase II study of ERK inhibition by ulixertinib (BVD-523) in metastatic uveal melanoma. Journal of Clinical Oncology. 38: 10036-10036. DOI: 10.1200/Jco.2020.38.15_Suppl.10036 |
0.381 |
|
| 2019 |
Montero J, Gstalder C, Kim DJ, Sadowicz D, Miles W, Manos M, Cidado JR, Paul Secrist J, Tron AE, Flaherty K, Stephen Hodi F, Yoon CH, Letai A, Fisher DE, Haq R. Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapies. Nature Communications. 10: 5157. PMID 31727958 DOI: 10.1038/S41467-019-12477-Y |
0.383 |
|
| 2019 |
Buchbinder EI, Weirather JL, Manos MP, Brennick RC, Ott PA, Haq R, Izar B, Hodi FS. Characterization of the genetics of mucosal melanoma in patients treated with immunotherapy. Journal of Clinical Oncology. 37: 9556-9556. DOI: 10.1200/Jco.2019.37.15_Suppl.9556 |
0.305 |
|
| 2018 |
Jerby-Arnon L, Shah P, Cuoco MS, Rodman C, Su MJ, Melms JC, Leeson R, Kanodia A, Mei S, Lin JR, Wang S, Rabasha B, Liu D, Zhang G, Margolais C, ... ... Haq R, et al. A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade. Cell. 175: 984-997.e24. PMID 30388455 DOI: 10.1016/J.Cell.2018.09.006 |
0.382 |
|
| 2018 |
Miao D, Margolis CA, Vokes NI, Liu D, Taylor-Weiner A, Wankowicz SM, Adeegbe D, Keliher D, Schilling B, Tracy A, Manos M, Chau NG, Hanna GJ, Polak P, Rodig SJ, ... ... Haq R, et al. Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors. Nature Genetics. PMID 30150660 DOI: 10.1038/S41588-018-0200-2 |
0.318 |
|
| 2018 |
Vokes N, Miao D, Margolis C, Liu D, Wankowicz S, Schilling B, Sholl LM, Getz G, Janne PA, Haddad RI, Choueiri TK, Barbie DA, Haq R, Awad MM, Schadendorf D, et al. Genomic correlates of response to immune checkpoint blockade in microsatellite stable solid tumors. Journal of Clinical Oncology. 36: 3036-3036. DOI: 10.1200/Jco.2018.36.15_Suppl.3036 |
0.311 |
|
| 2018 |
Gstalder C, Pancholi P, Sadowicz D, Haq R. Abstract 1698: Loss of MHC-I expression is associated with altered immune microenvironment and decreased response to PD-1 checkpoint inhibition Cancer Research. 78: 1698-1698. DOI: 10.1158/1538-7445.Am2018-1698 |
0.382 |
|
| 2017 |
Haq R. Trapping Cancers as They Adapt to Survive. Cancer Discovery. 7: 1216-1217. PMID 29097618 DOI: 10.1158/2159-8290.Cd-17-0976 |
0.327 |
|
| 2016 |
Gee MS, Ghazani AA, Haq R, Wargo JA, Sebas M, Sullivan RJ, Lee H, Weissleder R. Point of care assessment of melanoma tumor signaling and metastatic burden from μNMR analysis of tumor fine needle aspirates and peripheral blood. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 27993725 DOI: 10.1016/J.Nano.2016.12.006 |
0.382 |
|
| 2016 |
Montero J, Sadowicz DE, Ryan J, Yoon CH, Haq R, Letai A. Abstract 3491: Rational combination of targeted agents and BH3 mimetics to improve cancer treatment Cancer Research. 76: 3491-3491. DOI: 10.1158/1538-7445.Am2016-3491 |
0.36 |
|
| 2015 |
Lauss M, Haq R, Cirenajwis H, Phung B, Harbst K, Staaf J, Rosengren F, Holm K, Aine M, Jirström K, Borg Å, Busch C, Geisler J, Lønning PE, Ringnér M, et al. Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation. The Journal of Investigative Dermatology. 135: 1820-8. PMID 25705847 DOI: 10.1038/Jid.2015.61 |
0.346 |
|
| 2015 |
Johannessen C, Konieczkowski D, Abudayyeh O, Kim JW, Cooper Z, Piris A, Frederick D, Barzily-Rokni M, Straussman R, Haq R, Fisher D, Mesirov J, Hahn W, Flaherty K, Wargo J, et al. Abstract PR04: A melanoma transcriptional state distinction influences sensitivity to MAPK pathway inhibitors Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Pms14-Pr04 |
0.418 |
|
| 2015 |
Montero J, Sadowicz DE, Haq R, Letai A. Abstract C6: Antiapoptotic defense evolution in cancer: novel therapeutic strategies to restore cell death using dynamic BH3 profiling Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C6 |
0.39 |
|
| 2014 |
Frederick DT, Salas Fragomeni RA, Schalck A, Ferreiro-Neira I, Hoff T, Cooper ZA, Haq R, Panka DJ, Kwong LN, Davies MA, Cusack JC, Flaherty KT, Fisher DE, Mier JW, Wargo JA, et al. Clinical profiling of BCL-2 family members in the setting of BRAF inhibition offers a rationale for targeting de novo resistance using BH3 mimetics. Plos One. 9: e101286. PMID 24983357 DOI: 10.1371/Journal.Pone.0101286 |
0.377 |
|
| 2014 |
Konieczkowski DJ, Johannessen CM, Abudayyeh O, Kim JW, Cooper ZA, Piris A, Frederick DT, Barzily-Rokni M, Straussman R, Haq R, Fisher DE, Mesirov JP, Hahn WC, Flaherty KT, Wargo JA, et al. A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer Discovery. 4: 816-27. PMID 24771846 DOI: 10.1158/2159-8290.Cd-13-0424 |
0.43 |
|
| 2014 |
Haq R. Metabolic dysregulation in melanoma: cause or consequence? Cancer Discovery. 4: 390-1. PMID 24706656 DOI: 10.1158/2159-8290.Cd-14-0173 |
0.315 |
|
| 2014 |
Haq R, Fisher DE, Widlund HR. Molecular pathways: BRAF induces bioenergetic adaptation by attenuating oxidative phosphorylation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2257-63. PMID 24610826 DOI: 10.1158/1078-0432.Ccr-13-0898 |
0.385 |
|
| 2013 |
Haq R, Fisher DE. Improving apoptotic responses to targeted therapy. Oncotarget. 4: 1331. PMID 23934756 DOI: 10.18632/Oncotarget.1261 |
0.406 |
|
| 2013 |
Haq R, Shoag J, Andreu-Perez P, Yokoyama S, Edelman H, Rowe GC, Frederick DT, Hurley AD, Nellore A, Kung AL, Wargo JA, Song JS, Fisher DE, Arany Z, Widlund HR. Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. Cancer Cell. 23: 302-15. PMID 23477830 DOI: 10.1016/J.Ccr.2013.02.003 |
0.386 |
|
| 2013 |
Haq R, Yokoyama S, Hawryluk EB, Jönsson GB, Frederick DT, McHenry K, Porter D, Tran TN, Love KT, Langer R, Anderson DG, Garraway LA, Duncan LM, Morton DL, Hoon DS, et al. BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition. Proceedings of the National Academy of Sciences of the United States of America. 110: 4321-6. PMID 23447565 DOI: 10.1073/Pnas.1205575110 |
0.472 |
|
| 2011 |
Haq R, Fisher DE. Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3474-82. PMID 21670463 DOI: 10.1200/Jco.2010.32.6223 |
0.342 |
|
| 2006 |
McGill GG, Haq R, Nishimura EK, Fisher DE. c-Met expression is regulated by Mitf in the melanocyte lineage. The Journal of Biological Chemistry. 281: 10365-73. PMID 16455654 DOI: 10.1074/Jbc.M513094200 |
0.334 |
|
| 2002 |
Haq R, Brenton JD, Takahashi M, Finan D, Finkielsztein A, Damaraju S, Rottapel R, Zanke B. Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Research. 62: 5076-82. PMID 12208764 |
0.617 |
|
| 2002 |
Ho JM, Nguyen MH, Dierov JK, Badger KM, Beattie BK, Tartaro P, Haq R, Zanke BW, Carroll MP, Barber DL. TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathways. Blood. 100: 1438-48. PMID 12149229 DOI: 10.1182/Blood.V100.4.1438.H81602001438_1438_1448 |
0.636 |
|
| 2002 |
Haq R, Halupa A, Beattie BK, Mason JM, Zanke BW, Barber DL. Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases. The Journal of Biological Chemistry. 277: 17359-66. PMID 11875080 DOI: 10.1074/Jbc.M201842200 |
0.625 |
|
| 2001 |
Haq R, Randall S, Midmer M, Yee K, Zanke B. NKIATRE is a novel conserved cdc2-related kinase. Genomics. 71: 131-41. PMID 11161806 DOI: 10.1006/Geno.2000.6424 |
0.637 |
|
| 2000 |
Jones NL, Islur A, Haq R, Mascarenhas M, Karmali MA, Perdue MH, Zanke BW, Sherman PM. Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family. American Journal of Physiology. Gastrointestinal and Liver Physiology. 278: G811-9. PMID 10801274 DOI: 10.1152/Ajpgi.2000.278.5.G811 |
0.598 |
|
| 1999 |
Midmer M, Haq R, Squire JA, Zanke BW. Identification of NKIAMRE, the human homologue to the mitogen-activated protein kinase-/cyclin-dependent kinase-related protein kinase NKIATRE, and its loss in leukemic blasts with chromosome arm 5q deletion Cancer Research. 59: 4069-4074. PMID 10463609 |
0.552 |
|
| 1998 |
Haq R, Zanke B. Inhibition of apoptotic signaling pathways in cancer cells as a mechanism of chemotherapy resistance. Cancer Metastasis Reviews. 17: 233-9. PMID 9770120 DOI: 10.1023/A:1006075007857 |
0.62 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2020 |
Tyan K, Grover S, Dougan M, Sullivan RJ, Giobbie-Hurder A, Blum S, Ishizuka JJ, Qazi T, Elias R, Vora K, Ruan A, Martin-Doyle W, Eastman L, Davis M, Gargano M, ... Haq R, et al. Association of vitamin D intake with decreased risk of immune checkpoint inhibitor-induced colitis. Journal of Clinical Oncology. 38: 89-89. DOI: 10.1200/Jco.2020.38.5_Suppl.89 |
0.29 |
|
| 2013 |
Shoag J, Haq R, Zhang M, Liu L, Rowe GC, Jiang A, Koulisis N, Farrel C, Amos CI, Wei Q, Lee JE, Zhang J, Kupper TS, Qureshi AA, Cui R, et al. PGC-1 coactivators regulate MITF and the tanning response. Molecular Cell. 49: 145-57. PMID 23201126 DOI: 10.1016/J.Molcel.2012.10.027 |
0.29 |
|
| 2020 |
Grover S, Dougan M, Tyan K, Giobbie-Hurder A, Blum SM, Ishizuka J, Qazi T, Elias R, Vora KB, Ruan AB, Martin-Doyle W, Manos M, Eastman L, Davis M, Gargano M, ... Haq R, et al. Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitis. Cancer. PMID 32567084 DOI: 10.1002/Cncr.32966 |
0.287 |
|
| 2011 |
Yokoyama S, Woods SL, Boyle GM, Aoude LG, MacGregor S, Zismann V, Gartside M, Cust AE, Haq R, Harland M, Taylor JC, Duffy DL, Holohan K, Dutton-Regester K, Palmer JM, et al. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature. 480: 99-103. PMID 22080950 DOI: 10.1038/Nature10630 |
0.286 |
|
| 2012 |
Li J, Song JS, Bell RJ, Tran TN, Haq R, Liu H, Love KT, Langer R, Anderson DG, Larue L, Fisher DE. YY1 regulates melanocyte development and function by cooperating with MITF. Plos Genetics. 8: e1002688. PMID 22570637 DOI: 10.1371/Journal.Pgen.1002688 |
0.286 |
|
| 2013 |
Haq R, Fisher DE. Targeting melanoma by small molecules: challenges ahead. Pigment Cell & Melanoma Research. 26: 464-9. PMID 23611259 DOI: 10.1111/Pcmr.12109 |
0.286 |
|
| 2017 |
Wang DY, Eroglu Z, Ozgun A, Leger PD, Zhao S, Ye F, Luke JJ, Joseph RW, Haq R, Ott PA, Hodi FS, Sosman J, Johnson DB, Buchbinder EL. Clinical features of acquired resistance to anti-PD-1 therapy in advanced melanoma. Cancer Immunology Research. PMID 28396509 DOI: 10.1158/2326-6066.Cir-16-0287 |
0.269 |
|
| 2020 |
Slyper M, Porter CBM, Ashenberg O, Waldman J, Drokhlyansky E, Wakiro I, Smillie C, Smith-Rosario G, Wu J, Dionne D, Vigneau S, Jané-Valbuena J, Tickle TL, Napolitano S, Su MJ, ... ... Haq R, et al. Author Correction: A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nature Medicine. PMID 32587393 DOI: 10.1038/S41591-020-0976-3 |
0.265 |
|
| 1996 |
Waring JD, Haq R, Tamai K, Sabourin LA, Ikeda JE, Korneluk RG. Investigation of myotonic dystrophy kinase isoform translocation and membrane association. The Journal of Biological Chemistry. 271: 15187-93. PMID 8663097 DOI: 10.1074/Jbc.271.25.15187 |
0.264 |
|
| 2022 |
Bakouny Z, Sadagopan A, Ravi P, Metaferia NY, Li J, AbuHammad S, Tang S, Denize T, Garner ER, Gao X, Braun DA, Hirsch L, Steinharter JA, Bouchard G, Walton E, ... ... Haq R, et al. Integrative clinical and molecular characterization of translocation renal cell carcinoma. Cell Reports. 38: 110190. PMID 34986355 DOI: 10.1016/j.celrep.2021.110190 |
0.236 |
|
| 2019 |
Naik GS, Waikar SS, Johnson AEW, Buchbinder EI, Haq R, Hodi FS, Schoenfeld JD, Ott PA. Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition. Journal For Immunotherapy of Cancer. 7: 89. PMID 30922394 DOI: 10.1186/S40425-019-0512-5 |
0.235 |
|
| 2017 |
Lee H, Hodi FS, Giobbie-Hurder A, Ott PA, Buchbinder EI, Haq R, Tolaney S, Barroso-Sousa R, Zhang K, Donahue H, Davis M, Gargano ME, Kelley KM, Carroll RS, Kaiser UB, et al. Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy. Cancer Immunology Research. PMID 29079654 DOI: 10.1158/2326-6066.Cir-17-0208 |
0.231 |
|
| 2022 |
Montero J, Haq R. Adapted to Survive: Targeting Cancer Cells with BH3 Mimetics. Cancer Discovery. 12: 1217-1232. PMID 35491624 DOI: 10.1158/2159-8290.CD-21-1334 |
0.229 |
|
| 2014 |
Haq R, Flaherty K. The melanoma metastasis X-factor. Pigment Cell & Melanoma Research. 27: 698. PMID 24953382 DOI: 10.1111/Pcmr.12285 |
0.225 |
|
| 2021 |
Bi K, He MX, Bakouny Z, Kanodia A, Napolitano S, Wu J, Grimaldi G, Braun DA, Cuoco MS, Mayorga A, DelloStritto L, Bouchard G, Steinharter J, Tewari AK, Vokes NI, ... ... Haq R, et al. Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma. Cancer Cell. PMID 33711272 DOI: 10.1016/j.ccell.2021.02.015 |
0.224 |
|
| 2023 |
Buchbinder EI, Giobbie-Hurder A, Haq R, Ott PA. A phase I/II study of LY3022855 with BRAF/MEK inhibition in patients with Melanoma. Investigational New Drugs. PMID 37247116 DOI: 10.1007/s10637-023-01374-3 |
0.222 |
|
| 2021 |
Buchbinder EI, Weirather JL, Manos M, Quattrochi BJ, Sholl LM, Brennick RC, Bowling P, Bailey N, Magarace L, Ott PA, Haq R, Izar B, Giobbie-Hurder A, Hodi FS. Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade. Cancer Medicine. PMID 33724703 DOI: 10.1002/cam4.3789 |
0.221 |
|
| 2006 |
Prutkin JM, Haq R. A dish best served hot. The American Journal of Medicine. 119: 307-9. PMID 16564770 DOI: 10.1016/J.Amjmed.2005.07.030 |
0.217 |
|
| 2012 |
Haq RU, Shah AU, Khan AU, Ullah Z, Khan HU, Khan RA, Malik A. Antitussive and toxicological evaluation of Vitex negundo. Natural Product Research. 26: 484-8. PMID 21809956 DOI: 10.1080/14786419.2010.534472 |
0.209 |
|
| 2020 |
Conway JR, Dietlein F, Taylor-Weiner A, AlDubayan S, Vokes N, Keenan T, Reardon B, He MX, Margolis CA, Weirather JL, Haq R, Schilling B, Stephen Hodi F, Schadendorf D, Liu D, et al. Integrated molecular drivers coordinate biological and clinical states in melanoma. Nature Genetics. PMID 33230298 DOI: 10.1038/s41588-020-00739-1 |
0.193 |
|
| 2021 |
Ott PA, Nazzaro M, Pfaff KL, Gjini E, Felt KD, Wolff JO, Buchbinder EI, Haq R, Sullivan RJ, Lawrence DP, McDermott DF, Severgnini M, Giobbie-Hurder A, Rodig SJ, Stephen Hodi F. Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial. Journal For Immunotherapy of Cancer. 9. PMID 34772758 DOI: 10.1136/jitc-2021-003318 |
0.193 |
|
| 2020 |
Macedo N, Miller DM, Haq R, Kaufman HL. Clinical landscape of oncolytic virus research in 2020. Journal For Immunotherapy of Cancer. 8. PMID 33046622 DOI: 10.1136/jitc-2020-001486 |
0.155 |
|
| 2021 |
Tyan K, Baginska J, Brainard M, Giobbie-Hurder A, Severgnini M, Manos M, Haq R, Buchbinder EI, Ott PA, Hodi FS, Rahma OE. Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitors. Cancer Immunology, Immunotherapy : Cii. PMID 33481042 DOI: 10.1007/s00262-021-02855-1 |
0.137 |
|
| 2021 |
Naik GS, Buchbinder EI, Cohen JV, Manos MP, Johnson AEW, Bowling P, Aizer AA, Schoenfeld JD, Lawrence DP, Haq R, Hodi FS, Sullivan RJ, Ott PA. Long-term Overall Survival and Predictors in Anti-PD-1-naive Melanoma Patients With Brain Metastases Treated With Immune Checkpoint Inhibitors in the Real-world Setting: A Multicohort Study. Journal of Immunotherapy (Hagerstown, Md. : 1997). PMID 34406158 DOI: 10.1097/CJI.0000000000000385 |
0.132 |
|
| 2022 |
Wei AZ, Uriel M, Porcu A, Manos MP, Mercurio AC, Caplan MM, Hulse L, Seedor RS, Holovatska M, Francis J, Khan SA, McDonnell DE, Bogomolny D, Sato T, Marr BP, ... Haq R, et al. Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases. Frontiers in Oncology. 12: 961517. PMID 36212499 DOI: 10.3389/fonc.2022.961517 |
0.129 |
|
| 2009 |
Wójtowicz AM, van den Boom L, Chakrabarty A, Maggio N, Haq RU, Behrens CJ, Heinemann U. Monoamines block kainate- and carbachol-induced gamma-oscillations but augment stimulus-induced gamma-oscillations in rat hippocampus in vitro. Hippocampus. 19: 273-88. PMID 19173289 DOI: 10.1002/hipo.20508 |
0.121 |
|
| 2024 |
Bajwa HS, Uddin S, Uddin Z, Umar HM, Haq RU, Asad Khan AU. Functional Outcome Of Bristow-Latarjet Procedure In Post-Traumatic Recurrent Anterior Shoulder Instability. Journal of Ayub Medical College, Abbottabad : Jamc. 35: 670-674. PMID 38406958 DOI: 10.55519/JAMC-04-11645 |
0.12 |
|
| 2019 |
Jamal M, Rehman MU, Nabi M, Awan AA, Ali N, Sherkheli MA, Haq RU. Evaluation of safety profile and stress suppressant activity of Rosa moschata in mice. Pakistan Journal of Pharmaceutical Sciences. 32: 2659-2665. PMID 31969299 |
0.087 |
|
| 2014 |
Hollnagel JO, Maslarova A, Haq RU, Heinemann U. GABAB receptor dependent modulation of sharp wave-ripple complexes in the rat hippocampus in vitro. Neuroscience Letters. 574: 15-20. PMID 24796812 DOI: 10.1016/j.neulet.2014.04.045 |
0.085 |
|
| 2023 |
Lutzky J, Sullivan RJ, Cohen JV, Ren Y, Li A, Haq R. Phase 1b study of intravenous coxsackievirus A21 (V937) and ipilimumab for patients with metastatic uveal melanoma. Journal of Cancer Research and Clinical Oncology. PMID 36651961 DOI: 10.1007/s00432-022-04510-3 |
0.085 |
|
| 2018 |
Berndt N, Rösner J, Haq RU, Kann O, Kovács R, Holzhütter HG, Spies C, Liotta A. Possible neurotoxicity of the anesthetic propofol: evidence for the inhibition of complex II of the respiratory chain in area CA3 of rat hippocampal slices. Archives of Toxicology. PMID 30143847 DOI: 10.1007/S00204-018-2295-8 |
0.084 |
|
| 2011 |
Haq Ru, Farooq U, Wahab A, Raza M, Ahmad VU, Khan RA. Investigation of antitussive and toxicological activity of Ballota limbata in mice. Pharmaceutical Biology. 49: 627-32. PMID 21554006 DOI: 10.3109/13880209.2011.563317 |
0.07 |
|
| 2021 |
Mushtaq M, Haq RU, Anwar W, Marshall L, Bazhenov M, Zia K, Alam H, Hertel L, Awan AA, Martinetz T. A computational study of suppression of sharp wave ripple complexes by controlling calcium and gap junctions in pyramidal cells. Bioengineered. 12: 2603-2615. PMID 34115572 DOI: 10.1080/21655979.2021.1936894 |
0.067 |
|
| 2021 |
Sidgiddi S, Naqvi SMH, Shenoy M, Balraj DN, Kothari J, Gupta S, Haq R, Mittal R, Mehta S, Mane A. Efficacy and Safety of Novel Formulation of Clobetasol Propionate 0.025% Cream in Indian Moderate-to-Severe Psoriasis Patients: Phase-2a, Randomized 3-Arm Study. Dermatology and Therapy. PMID 34453262 DOI: 10.1007/s13555-021-00591-z |
0.058 |
|
| 2003 |
Haq RU, Pendlebury WW, Fries TJ, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients. Muscle & Nerve. 27: 465-70. PMID 12661048 DOI: 10.1002/mus.1250 |
0.057 |
|
| 2014 |
Bhavsar B, Choksi B, Sanmukhani J, Dogra A, Haq R, Mehta S, Mukherjee S, Subramanian V, Sheikh S, Mittal R. Clindamycin 1% Nano-emulsion Gel Formulation for the Treatment of Acne Vulgaris: Results of a Randomized, Active Controlled, Multicentre, Phase IV Clinical Trial. Journal of Clinical and Diagnostic Research : Jcdr. 8: YC05-9. PMID 25302253 DOI: 10.7860/JCDR/2014/9111.4769 |
0.056 |
|
| 2019 |
Usman M, Hamid M, Zubair T, Haq RU, Wang W. Operational-matrix-based algorithm for differential equations of fractional order with Dirichlet boundary conditions The European Physical Journal Plus. 134. DOI: 10.1140/epjp/i2019-12653-7 |
0.01 |
|
| 2003 |
Haq R. Age-old theories die hard. Clinical and Investigative Medicine. MéDecine Clinique Et Experimentale. 26: 116-20. PMID 12858945 |
0.01 |
|
| Hide low-probability matches. |